leisure time -WSS

leisure time

author：leisure time 2025-10-01 16:38:29 - browse：55724

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LEXINGTON, Mass. — New obesity drugs like Wegovy and Zepbound are currently taken once a week, indefinitely. But what if they could be taken once a year instead, like a vaccine?

That’s a question that Novo Nordisk, the pharma company behind Wegovy, is exploring as it faces increased competition from other drugmakers aiming to develop similar GLP-1-based treatments for obesity.

“We have a very early think tank on: what would it take us, from a technology point of view and from an ecosystem point of view, to make long-lasting GLP-1 molecules?” Marcus Schindler, Novo’s chief scientific officer, said in an interview with STAT Wednesday. “Could we think about vaccine-like properties, where imagine you had, once a year, an injection with an equivalent of a GLP-1 that really helps you to maintain weight loss and have cardiovascular benefits?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Illumina board agrees to spin off Grail, as divestment plans proceed

focus

WSS

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Akili, maker of video game for ADHD, to be acquired for 34 million

FDA approves Moderna’s RSV vaccine, its second licensed product

Data don't support strong claims for Covid

Do more moles mean more problems? Not so, says new study

Dark money group runs ads on China biotech bill

leisure time

leisure time

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Scientists successfully use ultrasound imaging to map brain activity

Cancer drug shortages should be causing more outrage

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Alkermes shareholders re

David Sabatini, ex

Alkermes shareholders re

Biohaven protein

Trump demands the U.S. pay no more for drugs than other countries … again

STAT wants to know your pick for a great summer read or listen

leisure time

FTC loses bid to block Novant's North Carolina hospital merger

Congress needs to close a vaccine

Finland to offer bird flu vaccine to select groups of people, a possible global first

Prosthetic arm enables patients to feel the objects they grip

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Adam's Biotech Scorecard: Do Sarepta's exon

entertainment

hotspot

Wikipedia

knowledge